Shannon Fishman

Title: Innovations by Shannon Fishman

Introduction

Shannon Fishman is an accomplished inventor based in Cambridge, MA (US). She has made significant contributions to the field of biotechnology, particularly in the development of RNA interference (RNAi) technologies. With a total of three patents to her name, Fishman is recognized for her innovative approaches to treating genetic disorders.

Latest Patents

One of her latest patents is titled "TMPRSS6 iRNA compositions and methods of use thereof." This invention relates to RNAi agents, specifically double-stranded RNAi agents that target the TMPRSS6 gene. The methods outlined in this patent aim to inhibit the expression of TMPRSS6 and provide treatment options for subjects suffering from TMPRSS6 associated disorders, such as iron overload conditions like β-thalassemia or hemochromatosis. This groundbreaking work has the potential to significantly impact the treatment landscape for these disorders.

Career Highlights

Shannon Fishman is currently employed at Alnylam Pharmaceuticals, Inc., where she continues to advance her research in RNAi technologies. Her work at Alnylam has positioned her as a key player in the biotechnology sector, contributing to the development of innovative therapies that address critical health issues.

Collaborations

Throughout her career, Fishman has collaborated with notable colleagues, including James Butler and Martin A Maier. These partnerships have fostered a collaborative environment that enhances the research and development of new therapeutic solutions.

Conclusion

Shannon Fishman is a pioneering inventor whose work in RNAi technologies is paving the way for new treatments for genetic disorders. Her contributions to the field are invaluable, and her ongoing research promises to bring hope to many patients.